Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/18566
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | MacIsaac, Richard J | - |
dc.contributor.author | Ekinci, Elif I | - |
dc.contributor.author | Premaratne, Erosha | - |
dc.contributor.author | Lu, Zhong X | - |
dc.contributor.author | Seah, Jas-Mine | - |
dc.contributor.author | Li, Yue | - |
dc.contributor.author | Boston, Ray | - |
dc.contributor.author | Ward, Glenn M | - |
dc.contributor.author | Jerums, George | - |
dc.date | 2015-12-03 | - |
dc.date.accessioned | 2018-08-30T06:23:38Z | - |
dc.date.available | 2018-08-30T06:23:38Z | - |
dc.date.issued | 2015-12-03 | - |
dc.identifier.citation | BMC nephrology 2015; 16: 198 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/18566 | - |
dc.description.abstract | Our hypothesis was that both the Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) equations would underestimate directly measured GFR (mGFR) to a similar extent in people with diabetes and preserved renal function. In a cross-sectional study, bias (eGFR - mGFR) was compared for the CKD-EPI and MDRD equations, after stratification for mGFR levels. We also examined the ability of the CKD-EPI compared with the MDRD equation to correctly classify subjects to various CKD stages. In a longitudinal study of subjects with an early decline in GFR i.e., initial mGFR > 60 ml/min/1.73 m(2) and rate of decline in GFR (ΔmGFR) > 3.3 ml/min/1.73 m(2) per year, ΔmGFR (based on initial and final values) was compared with ΔeGFR by the CKD-EPI and MDRD equations over a mean of 9 years. In the cross-sectional study, mGFR for the whole group was 80 ± 2.2 ml/min/1.73 m(2) (n = 199, 75 % type 2 diabetes). For subjects with mGFR >90 ml/min/1.73 m(2) (mGFR: 112 ± 2.0, n = 76), both equations significantly underestimated mGFR to a similar extent: bias for CKD-EPI: -12 ± 1.4 ml/min/1.73 m(2) (p < 0.001) and for MDRD: -11 ± 2.1 ml/min/1.73 m(2) (p < 0.001). Using the CKD-EPI compared with the MDRD equation did not improve the number of subjects that were correctly classified to a CKD-stage. No biochemical or clinical patient characteristics were identified to account for the under estimation of mGFR values in the normal to high range by the CKD-EPI equation. In the longitudinal study (n = 30, 66 % type 1 diabetes), initial and final mGFR values were 102.8 ± 6 and 54.6 ± 6.0 ml/min/1.73 m(2), respectively. Mean ΔGFR (ml/min/1.73 m(2) per year) was 6.0 by mGFR compared with only 3.0 by MDRD and 3.2 by CKD-EPI (both p < 0.05 vs mGFR) CONCLUSIONS: Both the CKD-EPI and MDRD equations underestimate reference GFR values > 90 ml/min/1.73 m(2) as well as an early decline in GFR to a similar extent in people with diabetes. There is scope to improve methods for estimating an early decline in GFR. | - |
dc.language.iso | eng | - |
dc.title | The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function. | - |
dc.type | Journal Article | - |
dc.identifier.journaltitle | BMC nephrology | - |
dc.identifier.affiliation | Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, 3065, Victoria, Australia | en |
dc.identifier.affiliation | Endocrine Centre, Heidelberg Repatriation Hospital, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne, 4th Floor, Daly Wing, 35 Victoria Parade, PO Box 2900, Fitzroy, VIC, 3065, Australia | en |
dc.identifier.affiliation | Menzies School of Health Research, Casuarina, 0811, Northern Territory, Australia | en |
dc.identifier.affiliation | Department of Medicine, Austin Health, University of Melbourne, Heidelberg, 3084, Victoria, Australia | en |
dc.identifier.affiliation | Melbourne Pathology, Collingwood, 3066, Victoria, Australia | en |
dc.identifier.affiliation | Clinical Chemistry, St Vincent's Hospital Melbourne, Fitzroy, 3065, Victoria, Australia | en |
dc.identifier.doi | 10.1186/s12882-015-0196-0 | - |
dc.identifier.orcid | 0000-0003-2372-395X | - |
dc.identifier.pubmedid | 26630928 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Ekinci, Elif I | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Endocrinology | - |
crisitem.author.dept | Endocrinology | - |
crisitem.author.dept | Endocrinology | - |
crisitem.author.dept | Endocrinology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.